About: Efficacy, safety and cost‐effectiveness of hydroxychloroquine in children with COVID‐19: A call for evidence

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy, safety and cost‐effectiveness of hydroxychloroquine in children with COVID‐19: A call for evidence Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Efficacy, safety and cost‐effectiveness of hydroxychloroquine in children with COVID‐19: A call for evidence
Creator	Sinha, Ian Fernandes, Ricardo Hawcutt, Daniel Pacheco, Leite Rafael, \| Rodriguez-Martinez, Carlos Rodríguez-Martínez, Carlos
Source	Medline; PMC
abstract	The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses a serious threat to public health and local economies around the globe. This has created an urgent need to identify effective medications for its prevention and treatment (1). Among these treatments, the off-label use of hydroxychloroquine (HCQ), a less toxic derivate of chloroquine, has become a common practice among clinicians, including pediatricians, despite lack of evidence of its clinical efficacy for this indication (especially for pediatric patients) at present time (2).
has issue date	2020-06-03(xsd:dateTime)
bibo:doi	10.1111/apa.15373
bibo:pmid	32438459
has license	no-cc
sha1sum (hex)	df46ceaf63ad708f897e8b21e8e3d9c149d9529b
schema:url	https://doi.org/10.1111/apa.15373
resource representing a document's title	Efficacy, safety and cost‐effectiveness of hydroxychloroquine in children with COVID‐19: A call for evidence
has PubMed Central identifier	PMC7280726
has PubMed identifier	32438459
schema:publication	Acta Paediatr
resource representing a document's body	covid:df46ceaf63ad708f897e8b21e8e3d9c149d9529b#body_text
is schema:about of	named entity 'hydroxychloroquine' named entity 'evidence' named entity 'safety' named entity 'ITS' covid:arg/df46ceaf63ad708f897e8b21e8e3d9c149d9529b named entity 'prevention' named entity 'chloroquine' named entity 'hydroxychloroquine' named entity 'chloroquine' named entity 'HCQ' named entity 'paediatric' named entity 'viral shedding' named entity 'hydroxychloroquine' named entity 'treatment options' named entity 'intensive care' named entity 'SARS-CoV-2 pandemic' named entity 'cost-effectiveness' named entity 'paediatric' named entity 'high-risk' named entity 'SARS-CoV-2' named entity 'short supply' named entity 'safety profile' named entity 'pharmacological' named entity 'high-quality' named entity 'SARS-CoV-2' named entity 'healthcare workers' named entity 'cost-effective' named entity 'prophylactic' named entity 'public health' named entity 'chloroquine' named entity 'paediatric' named entity 'meta-analysis' named entity 'COVID-19 pandemic' named entity 'viral shedding' named entity 'hydroxychloroquine' named entity 'Hydroxychloroquine' named entity 'SARS-CoV-2' named entity 'lungs' named entity 'virus' named entity 'infection' named entity 'community spread' named entity 'immunomodulatory' named entity 'HCQ' named entity 'antiviral' named entity 'paediatricians' named entity 'paediatric' named entity 'clinical trials' named entity 'COVID' named entity 'HCQ' named entity 'personal protective equipment (PPE' named entity 'middle-income' named entity 'cost-effectiveness analysis' named entity 'plasma' named entity 'clinical trials' named entity 'COVID-19' named entity 'viral shedding' named entity 'HCQ' named entity 'chloroquine' named entity 'lungs' named entity 'off-label' named entity 'SARS-CoV-2' named entity 'risks and benefits' named entity 'randomised controlled trials' named entity 'HCQ' named entity 'well-being' named entity 'hydroxychloroquine' named entity 'hydroxychloroquine' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'COVID-19' named entity 'off-label' named entity 'SARS-CoV-2' named entity 'hydroxychloroquine' named entity 'COVID -19' named entity 'paediatric' named entity 'PRACTICE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software